Skip to content

Clinical trials

Completed Phase 3 Prostatic Hyperplasia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Hyperplasia Phase: Phase 3 Status: Completed Clear all

56 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20032
20041
20055
20064
20072
20082
20097
20106
20114
20121
20134
20143
20152
20162
20181
20193
20201
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed56

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company9
GlaxoSmithKline5
Sanofi5
Nymox Corporation4
Health Ever Bio-Tech Co., Ltd.3
Watson Pharmaceuticals3
AEterna Zentaris2
Astellas Pharma Europe B.V.2
Hanmi Pharmaceutical Company Limited2
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Hyperplasia56
Lower Urinary Tract Symptoms9
Erectile Dysfunction3
Prostatic Neoplasms2
Urinary Bladder Neck Obstruction2
Urinary Bladder, Overactive2
Genital Diseases, Male1
Hyperplasia1
Metabolic Syndrome1
Neoplasms1

Trials

Showing 1 to 25 of 56. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.